Results 151 to 160 of about 6,496,822 (268)
Numerical study on fractional order nonlinear SIR-SI model for dengue fever epidemics. [PDF]
Verma L, Meher R, Nikan O, Al-Saedi AA.
europepmc +1 more source
Note on the existence of a large pelican in the turbaries of England [PDF]
Alphonse Milne‐Edwards
openalex +1 more source
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon+13 more
wiley +1 more source
Showing Up is Still Resistance: Contextualizing Black Trainee Resistance in Medical Education. [PDF]
Kas-Osoka OA, Poitevien P.
europepmc +1 more source
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková+14 more
wiley +1 more source
From Abstinence to Assistance: Antinatalism's Unexpected Endorsement of the Principle of Procreative Beneficence. [PDF]
Teo MTL.
europepmc +1 more source
XVII.—On the existence of capillary arterial vessels in insects [PDF]
Jules Künckel
openalex +1 more source
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim+11 more
wiley +1 more source
Addressing Threats to Research and Global Engagement in Human Biology. [PDF]
Leonard WR, Cameron N.
europepmc +1 more source
Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez+5 more
wiley +1 more source